In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment

Tractable experimental model that accounts for inter-tumor molecular heterogeneity is a key element of anti-cancer drug development. Hepatocellular carcinoma is known to exhibit highly heterogeneous molecular aberrations across the tumors, including somatic genetic and epigenetic alterations. Previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirschfield, Hadassa, Bian, C Billie, Higashi, Takaaki, Nakagawa, Shigeki, Zeleke, Tizita Z, Nair, Venugopalan D, Fuchs, Bryan C, Hoshida, Yujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992986/
https://www.ncbi.nlm.nih.gov/pubmed/29303513
http://dx.doi.org/10.1038/emm.2017.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992986/
https://www.ncbi.nlm.nih.gov/pubmed/29303513
http://dx.doi.org/10.1038/emm.2017.164

Ejemplares similares